These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16648510)

  • 41. Ixabepilone.
    Stein A
    Clin J Oncol Nurs; 2010 Feb; 14(1):65-71. PubMed ID: 20118028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    O'Connor OA; Portlock C; Moskowitz C; Straus D; Hamlin P; Stubblefield M; Dumetrescu O; Colevas AD; Grant B; Zelenetz A
    Br J Haematol; 2008 Oct; 143(2):201-9. PubMed ID: 18691173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
    Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P
    Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
    Plummer R; Woll P; Fyfe D; Boddy AV; Griffin M; Hewitt P; Carmichael J; Namouni F; Cohen M; Verrill M
    Clin Cancer Res; 2008 Dec; 14(24):8288-94. PubMed ID: 19088046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.
    Moore DH; Donnelly J; McGuire WP; Almadrones L; Cella DF; Herzog TJ; Waggoner SE;
    J Clin Oncol; 2003 Nov; 21(22):4207-13. PubMed ID: 14615449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C; Dufresne A; Pivot X; Viel E
    Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors.
    Zhang P; Sun M; Qiu R; Tang L; Dou G; Xu B
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):971-8. PubMed ID: 21305287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer.
    Perez EA; Patel T; Moreno-Aspitia A
    Breast Cancer Res Treat; 2010 Jun; 121(2):261-71. PubMed ID: 20229176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
    Morrow PK; Divers S; Provencher L; Luoh SW; Petrella TM; Giurescu M; Schmelter T; Wang Y; Hortobagyi GN; Vahdat LT
    Breast Cancer Res Treat; 2010 Oct; 123(3):837-42. PubMed ID: 20697802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
    Schilder RJ; LaCreta FP; Perez RP; Johnson SW; Brennan JM; Rogatko A; Nash S; McAleer C; Hamilton TC; Roby D
    Cancer Res; 1994 Feb; 54(3):709-17. PubMed ID: 8306332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
    Vansteenkiste J; Lara PN; Le Chevalier T; Breton JL; Bonomi P; Sandler AB; Socinski MA; Delbaldo C; McHenry B; Lebwohl D; Peck R; Edelman MJ
    J Clin Oncol; 2007 Aug; 25(23):3448-55. PubMed ID: 17606973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
    Spigel DR; Anthony Greco F; Waterhouse DM; Shipley DL; Zubkus JD; Bury MJ; Webb CD; Hart LL; Gian VG; Infante JR; Burris HA; Hainsworth JD
    Lung Cancer; 2012 Oct; 78(1):70-5. PubMed ID: 22947511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Relationship Between Peripheral Neuropathy Induced by Docetaxel and Systemic Inflammation-based Parameters in Patients with Breast Cancer.
    Yamanouchi K; Kuba S; Sakimura C; Morita M; Kanetaka K; Kobayashi K; Takatsuki M; Hayashida N; Eguchi S
    Anticancer Res; 2017 Dec; 37(12):6947-6951. PubMed ID: 29187478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Axonal neuropathy caused by epothilone B.
    Grewal RP
    Neurol India; 2007; 55(2):178-9. PubMed ID: 17558132
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of the stress level on the execution of the Grooved Pegboard Test.
    Petrigna L; Pajaujiene S; Mancuso EP; Barcellona M; Francavilla VC; Bianco A; Messina G
    J Sports Med Phys Fitness; 2022 Aug; 62(8):1023-1028. PubMed ID: 35860968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. JTH in clinic: A new series for the practicing clinician.
    Connors JM
    J Thromb Haemost; 2021 Jan; 19(1):51. PubMed ID: 33405378
    [No Abstract]   [Full Text] [Related]  

  • 58. JTH editorial v17 - The importance of psychosocial factors in transport and health.
    Musselwhite CBA
    J Transp Health; 2020 May; ():100876. PubMed ID: 32837912
    [No Abstract]   [Full Text] [Related]  

  • 59. For the May 2022 JTH issue.
    J Thromb Haemost; 2022 May; 20(5):1036. PubMed ID: 35445573
    [No Abstract]   [Full Text] [Related]  

  • 60. Change of hand sensation and function in patients with malignant lymphoma during early-stage vincristine chemotherapy: A single-center observational study.
    Iokawa K; Fujita T; Yoshida S; Mogi Y; Kasahara R; Yamamoto Y; Kai T
    Medicine (Baltimore); 2024 May; 103(20):e38207. PubMed ID: 38758870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.